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Oligomers and polymers of flavan-3-ols (proanthocyanidins) are very abundant in the Mediterranean diet, but are poorly absorbed. However, when
these polyphenols reach the colon, they are metabolised by the intestinal microbiota into various phenolic acids, including phenylpropionic, phe-
nylacetic and benzoic acid derivatives. Since the biological properties of these metabolites are not completely known, in the present study, we
investigated the effect of the following microbial phenolic metabolites: 3,4-dihydroxyphenylpropionic acid (3,4-DHPPA), 3-hydroxyphenylpropio-
nic acid, 3,4-dihydroxyphenylacetic acid (3,4-DHPAA), 3-hydroxyphenylacetic acid, 4-hydroxybenzoic acid and 4-hydroxyhippuric acid (4-HHA),
on modulation of the production of the main pro-inflammatory cytokines (TNF-a, IL-1b and IL-6). The production of these cytokines by lipopo-
lysaccharide (LPS)-stimulated peripheral blood mononuclear cells (PBMC) pre-treated with the phenolic metabolites was studied in six healthy
volunteers. With the exception of 4-HHA for TNF-a secretion, only the dihydroxylated compounds, 3,4-DHPPA and 3,4-DHPAA, significantly
inhibited the secretion of these pro-inflammatory cytokines in LPS-stimulated PBMC. Mean inhibition of the secretion of TNF-a by 3,4-DHPPA
and 3,4-DHPAA was 84·9 and 86·4%, respectively. The concentrations of IL-6 in the culture supernatant were reduced by 88·8 and 92·3% with
3,4-DHPPA and 3,4-DHPAA pre-treatment, respectively. Finally, inhibition was slightly higher for IL-1b, 93·1% by 3,4-DHPPA and 97·9% by
3,4-DHPAA. These results indicate that dihydroxylated phenolic acids derived from microbial metabolism present marked anti-inflammatory
properties, providing additional information about the health benefits of dietary polyphenols and their potential value as therapeutic agents.
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Polyphenols are among the most abundant antioxidant com-
pounds of the Mediterranean diet and may play a key role
in the prevention of cardiovascular and neurodegenerative dis-
eases, and cancer(1). Health effects derived from polyphenol
consumption depend on their bioavailability, a factor that
greatly varies from one compound to another(2). Among poly-
phenols, the oligomers and polymers of flavan-3-ols, also
called proanthocyanidins, are not absorbed or degraded into
monomers during their transit through the stomach(2,3).
However, when they reach the colon, they are metabolised
by the intestinal microbiota into various phenolic acids,
including phenylpropionic, phenylacetic and benzoic acid
derivatives(4). Hydroxycinnamic acid esters and polyphenols
linked to rhamnose are also degraded into phenolic acids by
the microbiota(2). Recently, it has been reported that these
metabolites may also exert several biological activities, such
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as the inhibition of platelet aggregation and activation func-
tion(5), inhibition of cyclo-oxygenase-2 in HT-29 colon
cancer cells(6), reduction in the synthesis of prostanoids in
colon cells(7), antiproliferative activity in prostate and cancer
cells(8) and, finally, influence cell proliferation, apoptosis
and signalling pathways in human colon carcinoma cells(9).
Atherosclerosis is now considered to be a low-grade chronic
inflammatory process resulting from the interactions between
plasma lipoproteins, cellular components (monocyte/macro-
phages, T lymphocytes, endothelial cells and smooth muscle
cells) and the extracellular matrix of arterial wall(10). Pro-
inflammatory cytokines are involved in all phases of the ather-
osclerotic process: they stimulate chemokines and adhesion
molecules, leading to early recruitment of monocytes and lym-
phocytes in the arterial intima, and later exert potential nox-
ious effects promoting weakening of plaques that are more
prone to rupture(10). However, data concerning the effect of
phenolic compounds on the production of the inflammatory
mediators from mononuclear cells are scarce and contradic-
tory. Some researchers(11) reported that polyphenols from
cocoa may reduce the expression of IL-2 mRNA in human
lymphocytes, and others(12) found differential effects of iso-
lated cocoa procyanidin fractions (monomer to decamers) on
the expression and secretion of IL-1b from peripheral blood
mononuclear cells (PBMC). In the same way, cocoa polyphe-
nols produced an increase in TNF-a secretion(13) or even a
down-regulation of IL-2 secretion and IL-2 receptor surface
expression on a lymphoid cell line(14), whereas in another
study, polyphenols from olive oil had no effect on the
secretion of TNF-a, IL-1b or IL-6 in the human whole
blood(15).
Considering the lack of information regarding the anti-
inflammatory properties of microbial-derived phenolic acids,
the aim of the present study was to investigate the effect of
some microbial phenolic metabolites on the modulation of
the production of the most representative pro-inflammatory
cytokines, i.e. TNF-a, IL-1b and IL-6, in lipopolysaccharide
(LPS)-stimulated PBMC from healthy human volunteers.
Methods
Six healthy volunteers (two men and four women) with an
average age of 29·3 (SD 2·1) years (range 27–33 years),
weight of 62·8 (SD 18·5) kg (range 50–100 kg), height of
1·7 (SD 0·1)m (range 1·6–1·9m) and BMI of 21·5 kg/m2 (SD
3·4) (range 17·9–27·7 kg/m2) participated in the study. None
of them reported a history of heart disease, homeostatic dis-
order or any other medical disease. None were receiving any
medication or taking any vitamin supplements. A 24 h food
recall questionnaire was used to assess their habitual nutrient
intake. This information was converted into dietary data
using the Professional Diet Balancer software (Cardinal
Health Systems, Inc., Edina, MN, USA) Their habitual
diet (mean of six volunteers) included an intake of
9789·81 kJ/d (2339·82 kcal/d); 117·41 g/d protein; 257·35 g/d
carbohydrates; 24·99 g/d dietary fibre; 5·27 g/d soluble fibre;
76·43 g/d total sugar (14·93 g/d monosaccharides, 31·27 g/d
disaccharides); 92·48 g/d of total fat (26·03 g/d saturated fat,
43·30 g/d monounsaturated fat, 15·93 g/d polyunsaturated
fat, 1·22 g/d trans-fatty acids, 221·87mg/d cholesterol);
863·77 retinol equivalents/d vitamin A; 2·33mg/d vitamin
B1; 2·39mg/d vitamin B2; 40·79mg/d vitamin B3; 2·49mg/d
vitamin B6; 7·77mg/d vitamin B12; 84·91mg/d vitamin C;
4·89mg/d vitamin D; 13·08mg/d vitamin E; 144·47mg/d esti-
mated polyphenol intake; 181·65mg/d phytoesterols.
Peripheral blood from the volunteers was collected and
PBMC were isolated by density gradient centrifugation over
Ficoll-Hypaque (Pharmacia, Uppsala, Sweden)(16). Harvested
cells were washed with PBS 10 £ buffer (Roche Diagnostics
GmbH, Mannheim, Germany) and then counted in a haemo-
cytometer chamber. Cell viability was estimated with trypan
blue. PBMC were resuspended in RPMI-1640 (Biowhittaker,
Verviers, Belgium) containing fetal bovine serum (10%) and
gentamicin (0·05mg/ml) (RPMI-10% fetal) up to a concen-
tration of 1 £ 106 viable cells/ml.
For each of the following phenolic acids, a 3mM solution
was prepared in RPMI-10% fetal: 3,4-dihydroxyphenylpro-
pionic acid (3,4-DHPPA); 3-hydroxyphenylpropionic acid
(3-HPPA); 3,4-dihydroxyphenylacetic acid (3,4-DHPAA); 3-
hydroxyphenylacetic acid (3-HPAA); 4-hydroxybenzoic acid
(4-HBA; Sigma-Aldrich, St Louis, MO, USA); 4-hydroxyhip-
puric acid (4-HHA; PhytoLab GmbH & Co. KG,
Vestenbergsgreuth, Germany).
PBMC were cultured with the different phenolic acid sol-
utions in the presence of LPS (Sigma-Aldrich). Five hundred
microlitres of the 1 £ 106 cells/ml suspension (5 £ 105 cells,
total number of cells) were pre-treated (16 h at 378C, 5%
CO2) with 250ml of the 3mM-phenolic acid solution (1mM,
final concentration with cells) in twenty-four-well plates.
After the pre-treatment period, the cell viability was estimated
with trypan blue and was higher than 95%. LPS (1mg/ml) was
then added to the culture followed by incubation for 72 h at
378C. Unstimulated and LPS-stimulated polyphenol-free
cells were also cultured under the same conditions. Exper-
iments were performed in duplicate. After the incubation
period, the cultures were centrifuged and the supernatant col-
lected and stored at 2808C until analysis. Pro-inflammatory
cytokines IL-1b, IL-6 and TNF-a were determined in the cul-
ture supernatants by ELISA (Bender Med Systems GmbH,
Vienna, Austria). Detection limits were as follows: 0·7 pg/ml
for IL-1b; 0·92 ng/ml for IL-6; 1·65 pg/ml for TNF-a.
For the statistical treatment of the data, t test for paired
samples were performed using the PC software package
SPSS version 14.0 (SPSS Inc., Chicago, IL, USA). Differences
between values were expressed as the percentage of enhance-
ment or inhibition. All statistical tests were two-tailed, and the
significance level was 0·05.
Results
The effects of tested phenolic acids on the secretion of TNF-a,
IL-1b and IL-6 from the PBMC of healthy subjects are shown
in Fig. 1 and Table 1. Stimulation of PBMC with LPS signifi-
cantly increased the levels of the three pro-inflammatory cyto-
kines up to 295·48 pg/ml (min ¼ 48·34, max ¼ 773·45) for
TNF-a, 128·38 pg/ml (min ¼ 44·24, max ¼ 209·91) for IL-
1b and 386·58 pg/ml (min ¼ 331·36, max ¼ 475·57) for IL-6.
3,4-DHPPA, 3,4-DHPAA and 4-HHA significantly reduced
(P,0·01 for 3,4-DHPPA and 3,4-DHPAA, P,0·05 for 4-
HHA) TNF-a secretion in LPS-stimulated PBMC by 84·9,
86·4 and 30·4%, respectively (Table 1). Contrarily, 4-HBA
significantly increased TNF-a secretion by 9·9%.No significant

















changes in TNF-a secretion were recorded after the addition of
the remaining tested phenolic acids, 3-HPPA and 3-HPAA. In
the case of IL-1b, only 3,4-DHPPA and 3,4-DHPAA signifi-
cantly (P,0·001) reduced the secretion of this cytokine in
LPS-stimulated PBMC by 93·1 and 97·9%, respectively
(Fig. 1; Table 1). Similarly, a significant reduction (P,0·001)
in IL-6 secretion fromLPS-stimulated PBMCwas also observed
after treatment with 3,4-DHPPA and 3,4-DHPAA, resulting in
Fig. 1. Effect of phenolic acids (1mM) derived from microbial metabolism on the secretion of (a) TNF-a, (b) IL-1b and (c) IL-6, after stimulation with lipopolysaccharide
(LPS) in peripheral blood mononuclear cells from six subjects (B, 1; A, 2; , 3; , 4; , 5; , 6). 3,4-DHPPA, 3,4-dihydroxyphenylpropionic acid; 3-HPPA, 3-hydroxy-
phenylpropionic acid; 3,4-DHPAA, 3,4-dihydroxyphenylacetic acid; 3-HPAA, 3-hydroxyphenylacetic acid; 4-HBA, 4-hydroxybenzoic acid; 4-HHA, 4-hydroxyhippuric acid.

















an inhibition of 88·8 and 92·3%, respectively. However, no sig-
nificant changes were found in IL-1b and IL-6 levels after the
addition of the remaining tested phenolic acids.
Discussion
In the present study, we observed that dihydroxylated phenolic
acids derived from microbial metabolism presented marked
in vitro anti-inflammatory properties, reducing the secretion
of TNF-a, IL-1b and IL-6 in LPS-stimulated PBMC from
healthy subjects. Six different phenolic acids (3,4-DHPPA,
3-HPPA, 3,4-DHPAA, 3-HPAA, 4-HBA and 4-HHA) derived
from the microbial metabolism of polyphenols, in particular
from monomeric flavanols and proanthocyanidins, were
tested at a concentration level (1mM) within the range (0·1–
10mM) found in plasma samples after the intake of a polyphe-
nol-rich meal and recommended for in vitro studies(3). Tested
compounds were chosen on the basis of their structural fea-
tures (i.e. hydroxylation pattern and side-chain length of the
functional group) and on their abundance in biological fluids
after the ingestion of polyphenol-rich foods. To our knowl-
edge, the effects of microbial-derived phenolic acids on the
production and release of pro-inflammatory cytokines from
human PBMC have not been published previously.
Previous studies based on the consumption of catechin by
human subjects resulted in an increase in 3-HPPA(17). Con-
sumption of catechins and proanthocyanidins from chocolate
by human subjects resulted in an increased urinary excretion
of 3-HPPA, 3,4-DHPAA, 3-HPAA and 3-HBA(18). More
recently, Ward et al. (19) described that 3-HPPA was the
main metabolite in urine when the human subjects were sup-
plemented with grape-seed polyphenols. Studies on laboratory
animals have shown similar results. Main urinary metabolites
formed from rats fed a catechin diet were 3-HPPA, 3-HBA
and 3-HPA(20). Besides these metabolites, 3-HPAA and
4-HBA were detected in the urine of rats fed wine polyphe-
nols(20). In vitro experiments also confirmed that 3-HPPA
was the most abundant metabolite produced from proantho-
cyanidin polymers(4) by human colonic microflora, whereas
3,4-DHPAA was the main metabolite from rutin, which was
further dehydroxylated to 3-HPAA(21). This compound was
also found to be the major end product of the colonic metab-
olism of chlorogenic acid by human faecal microbiota
in vitro (22). The yield of microbial metabolites could be
high, in particular for the polyphenols that are poorly absorbed
in the small intestine. For example, for chlorogenic and caffeic
acids, it represented 57·4 and 28·1% of the total intake,
respectively(22). However, in order for these metabolites to
be effective at a physiological level, they need to be absorbed
and reach target tissues. In fact, once produced by the micro-
biota, some colonic metabolites could be further absorbed and
reach the liver and the kidney where they could be methylated,
hydroxylated or conjugated with glycine(20,23). Recently, the
absorption mechanism of some of these colonic metabolites
is beginning to be elucidated. Metabolites such as ferulic,
p-coumaric, m-coumaric and 3-HPPA are absorbed by the
Table 1. Summary results of the effect of phenolic acids (1mM) derived from microbial metabolism on the secretion of
TNF-a, IL-1b and IL-6 after stimulation with lipopolysaccharide (LPS) in peripheral blood mononuclear cells from six
healthy subjects
(Mean values with their standard deviations)
n 6 Minimum Maximum Mean SD Enhancement or inhibition (%) P *
TNF-a (pg/ml)
Non-stimulated 5·73 40·55 18·23 11·51
LPS-stimulated 48·34 773·45 295·48 265·97
LPSþ 3,4-DHPPA 16·55 128·15 44·51 35·66 284·9 0·009
LPS þ 3-HPPA 87·07 709·68 313·14 232·76 þ6·0 0·588
LPS þ 3,4-DHPAA 17·95 72·51 40·06 18·35 286·4 0·007
LPS þ 3-HPAA 76·07 781·47 288·48 249·69 22·4 0·728
LPS þ 4-HBA 88·51 819·10 324·87 270·58 þ9·9 0·001
LPS þ 4-HHA 69·86 672·04 205·67 216·82 230·4 0·026
IL-1b (pg/ml)
Non-stimulated 4·36 28·12 11·39 7·41
LPS-stimulated 44·24 209·91 128·38 52·60
LPS þ 3,4-DHPPA 0·00 22·28 8·85 7·94 293·1 0·000
LPS þ 3-HPPA 97·49 236·79 138·57 46·73 þ10·5 0·192
LPS þ 3,4-DHPAA 0·00 12·00 2·72 4·65 297·9 0·000
LPS þ 3-HPAA 65·05 202·09 128·54 44·20 þ0·1 0·982
LPS þ 4-HBA 59·15 218·71 122·92 60·68 24·3 0·583
LPS þ 4-HHA 68·54 195·74 113·70 42·28 211·4 0·323
IL-6 (pg/ml)
Non-stimulated 27·51 264·91 161·22 73·60
LPS-stimulated 331·36 475·57 386·58 49·38
LPS þ 3,4-DHPPA 2·94 102·68 43·29 31·14 288·8 0·000
LPS þ 3-HPPA 324·35 456·42 378·79 48·03 22·0 0·138
LPS þ 3,4-DHPAA 2·94 99·42 29·59 33·18 292·3 0·000
LPS þ 3-HPAA 331·36 458·06 393·83 44·24 þ1·9 0·482
LPS þ 4-HBA 343·01 476·96 386·05 54·08 20·1 0·946
LPS þ 4-HHA 333·34 480·36 385·20 46·68 20·4 0·880
3,4-DHPPA, 3,4-dihydroxyphenylpropionic acid; 3-HPPA, 3-hydroxyphenylpropionic acid; 3,4-DHPAA, 3,4-dihydroxyphenylacetic acid;
3-HPAA, 3-hydroxyphenylacetic acid; 4-HBA, 4-hydroxybenzoic acid; 4-HHA, 4-hydroxyhippuric acid.
* Significant differences between LPS-stimulated cells and those in the presence of phenolic acids were determined by the t test.

















monocarboxylic acid transporter, whereas caffeic acid and 3,4-
DHPPA permeate across Caco-2 cells via the paracellular
pathway(24–26). Using immunohistochemical tests, Kawai
et al. (27) have recently confirmed that polyphenol metabolites
could penetrate the tissues. Quercetin-3-glucuronide, a major
metabolite of quercetin, was permeable in LPS-stimulated
macrophages, and was converted into the more active
aglycone, a part of which was further converted into the
methylated form. These data suggest that microbial
phenolic metabolites could also undergo a similar pathway
in injured cells.
Atherosclerosis is now considered as an inflammatory dis-
ease(28). Recent epidemiological and clinical studies have
shown that the Mediterranean diet or its main components,
rich in polyphenols, are associated with a lower inflammatory
status(29). However, in epidemiological and even in clinical
studies, it is difficult to control the effects of the diet
consumed and physical activity performed(30). Thus, in vitro
studies allow us to obtain additional information in relation
to the direct effect of some compounds (i.e. polyphenol metab-
olites) in biochemical pathways related to cardiovascular
health, such as the production of pro-inflammatory cytokines
that participate in the first stages of atherosclerosis. LPS is a
bacterial protein and is used as a method to challenge
immune cells to produce cytokines, including the inflamma-
tory cytokines. Some of the inflammatory cytokines that are
produced are those that have been associated with chronic
inflammation and atherosclerosis risk.
The results found in the present study indicate that the
effects of the tested phenolic acids on cytokine secretion by
PBMC were structure dependent. With the exception of the
effects of 4-HHA on TNF-a secretion, only the dihydroxy-
lated phenolic acids, 3,4-DHPPA and 3,4-DHPAA, caused a
statistically significant decrease in the secreted levels of the
three different cytokines from LPS-stimulated PBMC
(Table 1). The standard deviation of the data reflects large
inter-individual difference in cytokine secretion among the
volunteers. In addition, the degree of inhibition was found to
be influenced by the cytokine family. The inhibition of
IL-1b by both compounds was slightly higher than that for
TNF-a and IL-6 (Table 1). Monohydroxylated phenolic
acids (3-HPPA, 3-HPAA, 4-HBA and 4-HHA) did not pro-
duce significant changes in cytokine secretion with the excep-
tion of 4-HHA on TNF-a secretion, which produced a
significant increase in this cytokine.
The present results on TNF-a, IL-1b and IL-6 secretion are in
agreement with other studies performed with other polyphenols
and cell types. Quercetin inhibited the expression of IL-8 and
MCP-1 in TNF-a-stimulated synovial cells(31). Small oligo-
meric procyanidin fractions (monomer to tetramer) isolated
from cocoa reduced the secretion of IL-1 from PHA-stimulated
PBMC, whereas polymers (pentamer to decamer) produced an
increase in the secreted levels(12). However, the same fractions
promoted the secretion of TNF-a(13). Dimeric flavanols isolated
frompine bark also enhancedTNF-a levels in stimulatedmacro-
phages, while monomers strongly inhibited its secretion(32).
Ramiro et al. (33) found that epicatechin, isoquercitrin and
cocoa extracts decrease the secretion of TNF-a bymacrophages
in a dose-dependent manner. Also in this line, it has also
been reported that several flavones and flavanols inhibited
TNF-a secretion by LPS-stimulated macrophages(34).
The superior effect of dihydroxylated phenolic acids in
comparison with the monohydroxylated ones on the inhibition
of pro-inflammatory cytokines has also been reported for other
tested biological properties. Thus, 3,4-DHPAA showed more
potent cytotoxicity against tumour cell lines than 4-hydroxy-
phenylacetic acid(8). 3,4-DHPPA was also among the phenolic
acids inhibiting the expression of P-selectin in resting plate-
lets(5). According to Russell et al. (35), dihydroxylated phenolic
acids present a better antioxidant capacity than monohydroxy-
lated ones due to their stabilisation into quinones.
The mechanism associated with the inhibitory or stimu-
latory activities of polyphenols on cytokine production may
result from transcriptional and post-transcriptional events(14).
In fact, NF-kB, a transcription factor responsible for the acti-
vation of a series of cytokines, including TNF-a and IL-1b, is
redox sensitive, and it is well known that the antioxidants such
as flavonoids can inhibit its activation(32). Other authors have
recently suggested that, besides their antioxidant effects, poly-
phenols could also function as signalling molecules(36).
In this sense, Tedgui & Mallat(10) have suggested that future
therapeutic approaches to treat atherosclerosis may include
agents that block pro-inflammatory cytokine signalling or
the transcription of inflammatory-mediating molecules,
among others. The results found in the present study demon-
strate that due to their down-regulating effect on the pro-
duction of pro-inflammatory cytokines TNF-a, IL-1b and
IL-6, polyphenols such as dihydroxylated phenolic acids
derived from microbial metabolism could be among the new
generation of therapeutic agents for the management of
immunoinflammatory diseases such as atherosclerosis.
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